Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes.
- 1 January 1999
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 44 (10) , 2020-2026
- https://doi.org/10.1023/a:1026670301787
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Importance of the Bcl-2 family in cell death regulationCellular and Molecular Life Sciences, 1996
- βII Protein Kinase C Is Required for the G2/M Phase Transition of Cell CyclePublished by Elsevier ,1996
- Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitorJournal of Neurosurgery, 1995
- Protein kinase C involvement in apoptosisGeneral Pharmacology: The Vascular System, 1995
- Potentiation of Apoptosis by Treatment With the Protein Kinase C-Specific Inhibitor Safingol in Mitomycin C-Treated Gastric Cancer CellsJNCI Journal of the National Cancer Institute, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- Cooperative interaction between c-myc and bcl-2 proto-oncogenesNature, 1992
- Features of apoptotic cells measured by flow cytometryCytometry, 1992
- Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisoneCellular Immunology, 1990